The mechanisms by which the microtubule cytoskeleton regulates the permeability of endothelial barrier are not well understood. Here, we demonstrate that microtubule-associated end-binding protein 3 (EB3), a core component of the microtubule plusend protein complex, binds to inositol 1,4,5-trisphosphate receptors (IP 3 Rs) through an S/TxIP EBbinding motif. In endothelial cells, a-thrombin, a pro-inflammatory mediator that stimulates phospholipase Cb, increases the cytosolic Ca 2+ concentration and elicits clustering of IP 3 R3s. These responses, and the resulting Ca 2+ -dependent phosphorylation of myosin light chain, are prevented by depletion of either EB3 or mutation of the TxIP motif of IP 3 R3 responsible for mediating its binding to EB3. We also show that selective EB3 gene deletion in endothelial cells of mice abrogates a-thrombininduced increase in endothelial permeability. We conclude that the EB3-mediated interaction of IP 3 Rs with microtubules controls the assembly of IP 3 Rs into effective Ca 2+ signaling clusters, which thereby regulate microtubule-dependent endothelial permeability.
In Brief
End binding proteins (EBs) mediate interactions between growing microtubules and intracellular structures.
Geyer et al. demonstrate that interactions between EB3 and IP 3 receptors control clustering of IP 3 receptors in endothelial cells and Ca 2+ signaling, and thus permeability of endothelial barrier in inflammatory diseases.
INTRODUCTION
Adherens junctions (AJs) responsible for endothelial cell interactions (Dejana, 2004) and acto-myosin contraction (Wainwright et al., 2003) regulate the integrity of the vascular endothelial barrier. The ectodomain of vascular endothelial (VE)-cadherin, which is the primary adhesion molecule of AJs, undergoes homophilic trans-dimerization to form AJs, while its intracellular domain interacts with the actin cytoskeleton (Daneshjou et al., 2015; Giannotta et al., 2013) . Activation of phospholipase C (PLC) via G protein-coupled receptors (GPCRs), such as the protease-activated receptor-1 (PAR-1), or by disruption of VE-cadherin trans-interactions , causes increased endothelial permeability (Komarova and Malik, 2010 ). An increase in cytosolic Ca 2+ concentration ([Ca 2+ ] c ), by promoting disassembly of AJs and acto-myosin-mediated contraction of endothelial cells, is a crucial signal mediating this increased endothelial permeability (Komarova and Malik, 2010) . The roles of actin polymerization and disassembly of AJs in increasing endothelial permeability have received considerable attention, but microtubules may also contribute to the response by poorly understood mechanisms . Microtubules are polarized tubular filaments of heterodimers of a-and b-tubulin, with distinct plus and minus ends (Howard and Hyman, 2003) . Plus ends, usually directed toward the cell periphery, undergo cycles of polymerization and depolymerization regulated by plus-end tracking proteins (+TIPs) (Akhmanova and Steinmetz, 2010) . The end-binding proteins, EB1 and EB3, members of the RP/EB family, are core elements of the dynamic +TIP complex. EBs transiently bind to growing microtubules by recognizing the GTP-bound state of b-tubulin (Maurer et al., 2012) . EB binding enhances lateral contacts between tubulin molecules and prevents the transition from microtubule growth to shrinkage (''catastrophe'' events) (Komarova et al., 2009; Maurer et al., 2012) . In addition, EBs provide an essential hub for assembly of other +TIPs that facilitate interactions of microtubules with various macromolecules and organelles (Akhmanova and Steinmetz, 2010) . The latter include endoplasmic reticulum (ER), which is continuously remodeled through its interactions with microtubules (Pendin et al., 2011) . These interactions involve both tethering of the ER protein, stromal interaction molecule 1 (STIM1), to the +TIP complex by EB1, and the association of ER tubules with the plus-end directed microtubule motor protein, kinesin 1 (Friedman and Voeltz, 2011; Grigoriev et al., 2008) .
ER is the major intracellular Ca 2+ store. Inositol 1,4,5-trisphosphate receptors (IP 3 Rs) within ER membranes allow rapid release of Ca 2+ from the ER (Foskett et al., 2007; Taylor et al., 2014) . Emptying of ER Ca 2+ stores then causes clustering of STIM1, and this activates store-operated Ca 2+ entry into the cell across the plasma membrane (Wu et al., 2014) . (Smith et al., 2009 ). The recruitment of IP 3 R activity depends critically on the distribution of IP 3 Rs in ER membranes, wherein most IP 3 Rs appear to be mobile (Ferreri-Jacobia et al., 2005; Pantazaka and Taylor, 2011) . Stimulation of PLC causes reversible clustering of IP 3 Rs in cells (Chalmers et al., 2006; Tateishi et al., 2005) and within nuclear envelope IP 3 causes IP 3 Rs to cluster (Taufiq-Ur-Rahman et al., 2009) . Importantly in the context of the present study, IP 3 Rs associate with microtubules (Takei et al., 1998) and the association contributes to the redistribution of IP 3 Rs during sustained stimulation (Vermassen et al., 2003) , extension of neuronal growth cones (Zhang and Forscher, 2009) , and cell division (Mitsuyama and Sawai, 2001 ). There is, however, also evidence that IP 3 R clustering can persist after disruption of microtubules (Wilson et al., 1998; Taufiq-Ur-Rahman et al., 2009) . Studies using drugs (colchicine, nocodazole, and taxol) suppressing microtubule dynamics suggest an important role of microtubule cytoskeleton in organizing IP 3 -evoked Ca 2+ signals (Isshiki et al., 1998; Fogarty et al., 2000) . Perturbing the microtubule cytoskeleton inhibits receptor-activated release of Ca 2+ via IP 3 Rs (Tasaka et al., 1991) , prevents initiation of Ca 2+ waves (Bé liveau and Guillemette, 2009; Isshiki et al., 1998) , slows diffusion of IP 3 Rs within ER membranes (Ferreri-Jacobia et al., 2005) , disrupts local delivery of IP 3 to IP 3 Rs (Graier et al., 1998; Ribeiro et al., 1997) , and abolishes IP 3 -activated Ca 2+ spikes at the apical pole of secretory cells (Fogarty et al., 2000) . Many of these perturbations might result from effects of microtubules in organizing the ER, but there is also the possibility of more direct interactions with IP 3 Rs. The latter would be significant for vascular endothelial cells, where we have shown that PLC-evoked Ca 2+ signals cause dephosphorylation of EB3 leading to persistent growth of microtubules, disassembly of AJs, and increased endothelial permeability .
Here, we demonstrate a direct interaction between EB3 and the S/TxIP motif within IP 3 R3 that allows IP 3 Rs to associate with growing microtubule tips. Depletion of EB3 or disruption of the interaction with an IP 3 R3 point mutation prevents both clustering of IP 3 R3s and Ca 2+ signals elicited by activation of PAR-1. Further, selective deletion of the EB3 gene in endothelium in mice inhibits the increase in endothelial permeability elicited by activation of PAR-1. Thus, microtubule-associated EB3 plays an obligatory role in organizing IP 3 -induced Ca 2+ signaling, and, in turn, regulating endothelial permeability.
RESULTS

Loss of EB3 Impairs Ca 2+ Signaling in Endothelial Cells
In primary cultures of human lung microvascular endothelial cells (HLMVECs), a-thrombin stimulates PAR-1, a GPCR that causes activation of PLCb, formation of IP 3 and release of Ca 2+ from intracellular stores. Depletion of EB3, using small interfering RNA (siRNA) ( Figure S1A) Figures S1B and S1C ).
We used low-affinity, genetically encoded Ca 2+ indicators expressed in the lumen of the ER, G-CEPIA1er and the ratiometric indicator GEM-CEPIA1er (Suzuki et al., 2014) Figure 1E ). Stimulation of control cells with a-thrombin caused [Ca 2+ ] ER to fall to 96 ± 33 mM, whereas a-thrombin had no significant effect on cells treated with siRNA for EB3 (436 ± 122 mM) ( Figure 1E ). Furthermore, refilling of ER after restoration of extracellular Ca 2+ to cells stimulated with a-thrombin in Ca 2+ -free medium was faster in cells lacking EB3 ( Figure 1D ), consistent with reduced activation of IP 3 Rs after knockdown of EB3. These results demonstrate that loss of EB3 attenuates the release of Ca 2+ from intracellular stores elicited by a-thrombin without affecting the initial Ca 2+ content of the ER.
EB3 Binds to IP 3 Rs
To assess whether the effects of EB3 on Ca 2+ release involved reorganization of the microtubule network, we analyzed changes in microtubule dynamics after addition of a-thrombin using timelapse confocal imaging of EB1-GFP to mark growing microtubule tips. We chose EB1-GFP for this analysis because it does not rescue the inhibition of a-thrombin-evoked Ca 2+ signals after EB3 depletion, and nor does loss of endogenous EB1 affect Ca 2+ signals ( Figures 1A and 1B) . In confluent monolayers of HLMVECs treated with control siRNA, microtubules grew at 13.7 ± 3.1 mm/min, and they displayed frequent catastrophe events. Depletion of EB3 had no effect on the growth rate or catastrophe frequency ( Table 1 ), suggesting that EB3 did not affect microtubule dynamics under basal conditions. This finding is consistent with previous work demonstrating that most EB3 is phosphorylated in unstimulated HLMVECs, and therefore unable to promote persistent growth of microtubules . In the 2-3 min after stimulation of PAR-1 with a-thrombin, there was no effect on the catastrophe frequency, but the stimulation unexpectedly reduced microtubule growth rate in both control and EB3-siRNA-treated cells (Table 1 ; Figure S2 ). These results demonstrate that loss of EB3 has no discernible effect on microtubule dynamics under conditions where it attenuates a-thrombin-evoked Ca 2+ release. We therefore considered whether EB3 might regulate PLC or IP 3 Rs. We used the IP 3 biosensor, LIBRAvIII, in which IP 3 binding causes a decrease in intramolecular fluorescence resonance energy transfer (FRET) (Tanimura et al., 2009) , to measure cytosolic IP 3 concentrations in confluent monolayers of HLMVECs.
a-Thrombin caused a decrease in the FRET signal consistent with an increase in cytosolic IP 3 concentration. The response was similar in cells treated with control siRNA or siRNA to EB3 ( Figure S3A ). These results thus suggest that under conditions where loss of EB3 attenuates a-thrombin-evoked Ca 2+ signals, EB3 has no effect on a-thrombin-induced IP 3 formation. Alignment of IP 3 R sequences identified a conserved SxIP motif within a short region of disordered protein structure in all three mammalian IP 3 R subtypes ( Figure S3B ). This motif (residues 804-807 in human IP 3 R3), a signature of EB-interacting partners , is located downstream of the IP 3 -binding site. The interaction between full-length EB3 or its C-terminal region (residues 200-281), and IP 3 R3 was demonstrated in pull-down assays using immobilized (His6)-EBs expressed in bacteria and GFP-IP 3 Rs from lysates of HEK cells (Figures 2A, 2B, and S3C) . IP 3 R1 and IP 3 R2 also associated with full-length EB3 ( Figure 2C ). EB1 was less effective than EB3 in the pull-downs of GFP-IP 3 R3 ( Figure 2B ). For each IP 3 R subtype, the interaction with EB3 was weaker than that between EB3 and STIM1, another Ca 2+ signaling protein to which EB1 and EB3 bind (Grigoriev et al., 2008) (Figure S3D ). Interaction between endogenous EB3 and IP 3 R3 was confirmed by their co-immunoprecipitation ( Figure S3E ). Deletion of the acidic C-terminal tail of EB3 (EB3DAc), which contributes to the binding interface for the S/TxIP motif, abolished the interaction of IP 3 R3 with EB3 ( Figure 2B ). Mutation of the critical Thr within the TxIP motif of IP 3 R3 (T804A) also abolished the interaction with EB3 ( Figure 2C ). These results suggest a direct interaction between the C-terminal region of EB3 and the TxIP motif of IP 3 R3, an interaction that is probably shared with other IP 3 R subtypes.
In HLMVECs expressing EB3-mRFP and GFP-IP 3 R3, there were transient contacts between growing microtubule tips and GFP-IP 3 R3 in ER membranes ( Figure 2D ). However, GFP-IP 3 R3 did not form the ''comet-like'' structures described for STIM-1 associated with growing microtubule tips (Grigoriev et al., 2008; Pozo-Guisado et al., 2010) . This finding is consistent with the lower affinity of EB3 relative to STIM1 for IP 3 R3, because comets reveal the density of EB proteins, which declines with distance from the microtubule tip. We also observed quenching of the GFP fluorescence when EB3-mRFP-labeled microtubule tips made contact with ER tubules, suggesting an intermolecular FRET between EB3-mRFP and GFP-IP 3 R3 ( Figures 2D and 2E ). Focal photobleaching of the EB3-mRFP acceptor caused a transient increase in closely apposed fluorescence of the GFP-IP 3 R3 donor ( Figure 2F ), confirming an interaction between EB3 and IP 3 R3 in intact cells. There was no detectable FRET between ] ER measured before (basal) and after stimulation with a-thrombin (50 nM) using GEM-CEPIA1er in cells treated with control or EB3 siRNA. Results are from two independent experiments; ***relative to matched siRNA treatment without a-thrombin stimulation, using one-way ANOVA.
GFP-IP 3 R3 and another +TIP, mRFP-CLIP-170 ( Figure 2F ). The results thus indicate a specific interaction between EB3 and IP 3 R3 in intact human lung endothelial cells.
Interactions between EB3 and IP 3 R3 Regulate IP 3 R3 Dynamic and Activity Analysis of mRNA and protein expression demonstrated that in various human pulmonary endothelial cells, including HLMVECs, IP 3 R2 and IP 3 R3 were the major subtypes ( Figures S4A-S4C) . Immunostaining of HLMVECs revealed that IP 3 R3 formed puncta ( Figure 3A ), consistent with their assembly into clusters, as reported for IP 3 Rs in endothelial cells (Tran et al., 2014) . Depletion of EB3 had no effect on the expression of IP 3 R3 ( Figure S4D ), but it significantly reduced the number of IP 3 R3 clusters ( Figures 3A  and 3B ). EB3 depletion had no effect on IP 3 R2 clusters, which were observed in the perinuclear region in both control and EB3 siRNA-treated cells (Figures S4E and S4F) . The inhibition of IP 3 R3 clustering by depletion of EB3 was reversed by expression of a siRNA-resistant EB3, but not by expression of the EB3DAc mutant ( Figure 3B ) that does not bind to IP 3 R3 ( Figure 2B ).
GFP-IP 3 R3 also formed clusters in unstimulated HLMVECs, with fewer clusters in cells lacking EB3 ( Figure 3C ). This allowed dynamic imaging of GFP-IP 3 R3 distribution in response to receptor activation. Stimulation of HLMVECs expressing GFP-IP 3 R3 with a-thrombin evoked a rapid transient increase in IP 3 R3 clustering that peaked after $30 s and persisted for 190 ± 15 s (time for 90% of clusters to disappear) ( Figures 3C-3E ). Similar clustering of IP 3 Rs in response to stimuli that caused IP 3 R activation has been reported in other cells (Taufiq-Ur-Rahman et al., 2009; Tateishi et al., 2005) . Both the number of IP 3 R3 clusters after stimulation with a-thrombin and their lifespan (64 ± 28 s) were reduced in EB3-depleted HLMVECs ( Figures 3D and 3E) .
Residue T804 within the TEIP motif of IP 3 R3 was required for IP 3 R3 binding to EB3 ( Figure 2C ). Expression of GFP-IP 3 R3 (T804A) in HLMVECs attenuated a-thrombin-evoked Ca 2+ signals. This was evident from the smaller effects of a-thrombin on both the decrease in [Ca 2+ ] ER and increase in [Ca 2+ ] c in cells 6.6 ± 6.5
Growth rates of microtubules were calculated from the histogram of instantaneous displacement rates of microtubule tips between frames collected every 3 s ( Figure S2 ). Catastrophe frequency was calculated from the number of shortening events per min (Supplemental Experimental Procedures). Results are means ± SD (n = 7-8 cells). a Paired two-tailed Student's t test compared to unstimulated cells. expressing GFP-IP 3 R3(T804A) relative to those expressing GFP-IP 3 R3 (Figure 4 ). GFP-IP 3 R3(T804A) also formed fewer clusters than GFP-IP 3 R3, they barely responded to a-thrombin, and the few clusters that formed were short lived ( Figures 5A-5C ). We conclude that EB3, via its interaction with IP 3 R3 in endothelial cells, both dynamically regulates basal and agonist-evoked clustering of IP 3 R3 and the IP 3 -mediated Ca 2+ release induced by a-thrombin ( Figure 5D ).
Loss of EB3 Suppresses Vascular Leakage In Vivo
Ca 2+ signals, via both activation of protein kinase C a and myosin light chain (MLC) kinase, facilitate cell contraction and destabilization of AJs (Komarova and Malik, 2010; Vandenbroucke St Amant et al., 2012) . We therefore examined the effects of EB3 and IP 3 R3 on phosphorylation of MLC-II. We used human pulmonary artery endothelial cells (HPAECs) for these analyses because they are amenable to measurements of trans-endothelial electrical resistance (TEER), which directly report, in real time, changes in the integrity of AJs (Vandenbroucke St Amant et al., 2012; Szulcek et al., 2013) . Depletion of EB3 or IP 3 R3 (Figure S4C ) suppressed a-thrombin-induced phosphorylation of MLC-II in HPAECs (Figures 6A and 6B) . In confluent monolayers of HPAECs, a-thrombin induced a decrease in TEER, reflecting changes in cell shape and disruption of AJs between endothelial cells. The decrease in TEER was attenuated in cells lacking IP 3 R3 or EB3 ( Figures 6C and 6D) , consistent with the lesser a-thrombin-evoked phosphorylation of MLC-II in these cells.
These findings suggest that the interactions between EB3 and IP 3 R3, through their effects on a-thrombin-induced Ca 2+ signals, contribute to MLC-II activation and the increased permeability of the endothelial barrier. Ca 2+ signals in the endothelium play a critical role in regulating vascular permeability, a hallmark of acute lung injury and inflammation (Gandhirajan et al., 2013; Tauseef et al., 2012) . To determine the role of EB3 in vascular endothelium, we generated EB3-iECKO mice in which high-fidelity inducible deletion of the EB3 gene (Mapre3) was restricted to endothelial cells ( Figure S5 ). We then used lungs to determine the microvessel filtration coefficient (k f,c ), a measure of endothelial vascular permeability to liquid, in naive lungs and after activation of PAR-1 ( Figure 6E ). Lungs from control Tie2-CreER T2 -negative and EB3-iECKO mice had similar basal permeability, suggesting that EB3 is not essential in the adult microvasculature ( Figure 6E ). Infusion of a peptide agonist of PAR-1 (PAR1-AP) caused lung vascular hyper-permeability in wild-type, but not in EB3-iECKO mice (Figure 6E) , indicating a pivotal role of EB3 in mediating the lung vascular permeability response.
DISCUSSION
Here, we show that stimulation of PLCb as induced by the inflammatory mediator a-thrombin causes IP 3 R3s to assemble into clusters in the ER membrane of endothelial cells and that this event requires the association of the TxIP motif of IP 3 R3 with (D and E) Summary results (mean ± SEM from 11 cells in each group) show time course of GFP-IP 3 R3 clustering after addition of a-thrombin (at t = 0) and (E) the lifetime of the clusters (time taken for 90% of clusters to disappear). These analyses were performed using processed images in which clusters present before addition of a-thrombin were subtracted (see Experimental Procedures). **Using Student's t test. Depletion of EB3 reduced both the number and lifetime of the IP 3 R3 clusters. Figure S4 shows additional control experiments and related analyses of GFP-IP 3 R2.
EB3 located at the tip of growing microtubules. Disrupting this interaction inhibits Ca 2+ signaling, the phosphorylation of MLC-II, and the subsequent increase in endothelial permeability in response to a-thrombin.
The local density of IP 3 Rs in the ER membrane induced by IP 3 R clustering is thought to be responsible for the spatially organized nature of Ca 2+ signaling in distinct cellular domains (Isshiki et al., 1998; Low et al., 2010) . The spacing of IP 3 Rs is key in determining whether the Ca 2+ released stimulates the activity of neighboring IP 3 Rs, and hence propagates Ca 2+ signaling in a regenerative manner. Optimal clustering of IP 3 Rs is therefore believed to be a critical factor in Ca 2+ signaling (Shuai and Jung, 2003) . A major factor determining IP 3 R clustering may be IP 3 -evoked conformational changes in IP 3 Rs (Taufiq- Ur-Rahman et al., 2009; Tateishi et al., 2005) . Studies also showed that microtubules facilitated movement of IP 3 Rs in cells (Ferreri-Jacobia et al., 2005) , and further that disruption of microtubules inhibited IP 3 -evoked Ca 2+ spiking (Bé liveau and Guillemette, 2009; Fogarty et al., 2000) , suggesting a role of microtubules in the mechanism of IP 3 R clustering. However, Taufiq-Ur-Rahman et al. (2009) ] c ) evoked by a-thrombin. Individual data points (four to ten cells) and means ± SEM are plotted. ***, **Using one-way ANOVA.
(as opposed to EB1) in endothelial cells. The enhanced binding of EB3 to IP 3 R3 correlated with the requirement for EB3, rather than EB1, for a-thrombin-induced Ca 2+ signaling. The requirement for EB3 may also result from its binding to additional, asyet-unidentified proteins mediating clustering of IP 3 R3s. Indeed, residues surrounding the S/TxIP motif have been recently shown to recognize EB3 (Le sniewska et al., 2014) . Inhibition of a-thrombin-induced Ca 2+ signals by a fragment of EB3 (CtmRFP) that dimerizes with native EB3 and prevents binding to microtubules confirmed that the requirement for EB3 is associated with its ability to bind to the growing microtubule tips. The concept of EB3 binding to IP 3 R3 is further supported by our FRET analysis showing a close and specific apposition of IP 3 R3 and EB3 at microtubule tips. (B and C) Summary results (mean ± SEM from five to seven cells) show the number of clusters for GFP-IP 3 R3 and GFP-IP 3 R3(T804A) (B) and cluster lifetime (C) after stimulation with a-thrombin (50 nM at t = 0). Data were analyzed using processed images as in Figures 3D and 3E We found that IP 3 R3 and IP 3 R2 are the major IP 3 R subtypes in endothelial cells. IP 3 R2s are concentrated in perinuclear regions and clustered in unstimulated endothelial cells. The perinuclear distribution of IP 3 R2 (Pantazaka and Taylor, 2011) and their propensity to cluster in unstimulated cells are also observed in other cells Sheppard et al., 1997) . The latter finding suggests that basal levels of IP 3 are sufficient to stimulate IP 3 R2 clustering, consistent with the greater affinity of IP 3 R2 for IP 3 relative to other subtypes (Iwai et al., 2007) . In unstimulated endothelial cells, however, IP 3 R3s are more widely distributed and less clustered than IP 3 R2s. The key role of IP 3 R3 in mediating a-thrombin-induced Ca 2+ signals is therefore probably due to their proximity to IP 3 produced by PLC at the plasma membrane. Our observation that a-thrombin augments the clustering of IP 3 R3s is consistent with their lower sensitivity to IP 3 (Iwai et al., 2007) . IP 3 -induced clustering of IP 3 R3s in the nuclear envelope did not require microtubules (Taufiq-Ur-Rahman et al., 2009) , and yet in endothelial cells clustering requires EB3-mediated interaction of IP 3 R3 with microtubules. The discrepancy may reflect a need for microtubules to facilitate movement of IP 3 Rs within the crowded cytoplasm of intact cells and stabilize IP 3 R clusters once they have formed.
We conclude that EB3-mediated tethering of IP 3 R3s to microtubule tips in endothelial cells is required to assemble the Ca 2+ signaling machinery. Moreover, a-thrombin stimulates formation of IP 3 at the plasma membrane, where it facilitates the clustering of IP 3 R3 via EB3-mediated interaction with microtubules. We propose that IP 3 R3 clustering enables Ca 2+ -mediated amplification of IP 3 -induced Ca 2+ release through activation of neighboring IP 3 Rs. The IP 3 -evoked Ca 2+ signaling can therefore be attenuated in the absence of this amplification step. The physiological importance of the EB3-IP 3 R3 interaction is evident from results in lung microvessels showing that endothelial cell-specific knockout of EB3 prevents the increase in endothelial permeability in response to inflammatory signal. Thus, microtubule-associated EB3 interacts directly with IP 3 Rs to assemble the Ca 2+ signaling complex at the ER membrane, and disruption of EB3-IP 3 R interaction may be an attractive therapeutic target for vascular inflammation.
EXPERIMENTAL PROCEDURES Materials
Sources of the expression constructs, antibodies, and siRNAs are provided in Supplemental Experimental Procedures. mRFP-(rat)CLIP-170 was generated from EGFP-CLIP-170 (Komarova et al., 2005) by substituting EGFP with monomeric RFP. For EB3-Ct-mRFP, the C terminus (residues 200-281) of EB3 was amplified by PCR and sub-cloned into the pmRFP-N1 vector (a gift from Dr. R. Tsien) at Sal1 and BamH1 sites. Expression constructs for the siRNA-insensitive form of EB3 and for EGFP-IP 3 R3(T804A) were generated using the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies).
DAPI was from Sigma. Human a-thrombin was from Fisher Scientific. The PAR-1-activating peptide (PAR1-AP, TFLLRN-NH 2 , $90% purity) was synthesized by the Research Resources Core at UIC. Sources of other materials are provided in the relevant sections in Experimental Procedures.
Pull-Down Assays with EB Proteins
Preparation of bacterially expressed (His6)-tagged EB proteins and their covalent immobilization on Ni-NTA columns for pull-down experiments using lysates from HEK cells expressing GFP-tagged proteins are described in Supplemental Experimental Procedures.
Cell Culture and Transfections
HPAECs and HLMVECs (Lonza) were grown in EGM-2 medium supplemented with 10% fetal bovine serum (FBS) and EGM-2 MV Bulletkit or EGM-2 Bulletkit (Lonza), respectively. Cells were used between passages 2 and 6. CHO-K1 and HEK293 cells (ATCC) were grown in DMEM with 10% FBS (Gibco). Cells were transfected at $80% confluence using X-tremeGENE HP according to the manufacturer's protocol (Roche) and used after 24-48 hr. For siRNA-mediated inhibition of protein expression, cells were treated with 70 nM siRNA (Supplemental Experimental Procedures) using GeneSilencer transfection reagent according to the manufacturer's protocol (Genlantis) and used after 72-96 hr. For experiments in which cells were stimulated with a-thrombin, the FBS concentration of the culture medium was reduced to 0.5% for 1 hr before the experiment.
Measurements of [Ca 2+ ] c
HLMVECs grown on glass-bottomed dishes (Becton Dickinson) were loaded with fura-2 AM (3 mM, Life Technologies) for 20 min at 37 C in culture medium without supplements. The medium was then replaced with medium comprising: 150 mM NaCl, 4 mM KCl, 1 mM MgCl 2 , 5.6 mM glucose, and 25 mM HEPES (pH 7.4), and, after $10 min, cells were used for experiments at 25 C. Fura-2 fluorescence was excited at 340 and 380 nm and collected at 510 ± 80 nm using an Axiovert 100 inverted microscope (Carl Zeiss) equipped with Plan-Apo 603 with the numerical aperture (NA) 1.4 oil immersion objective, Lambda DG-4 switcher illumination system (Sutter Instruments), AxioCom Hsm camera (Zeiss), fura-2 filter set (Chroma), and AxioVision Physiology Acquisition module. Images were collected at 2-s intervals. Fluorescence ratios (F 340 /F 380 ) were calculated within a circular region of interest (radius 3 mm) for each cell after subtraction of intracellular background fluorescence, determined by quenching fura-2 fluorescence by addition of 3 mM ionomycin with with the GEM-CEPIA1er ratiometric indicator (Suzuki et al., 2014) . Analyses were performed at 37 C in the Ca 2+ -free medium described above using a confocal microscope (Zeiss LSM 710, Axio Observer Z1) equipped with a 633 1.4 NA Plan-Apochromat oil immersion objective and a diode-pumped solid-state laser. Cells were excited at 405 nm, and emission was collected by two photomultiplier tubes (456-476 and 510-530 nm). Images (5-10/cell) were collected at 1-s intervals, averaged over four frames to optimize signalto-noise ratios, and fluorescence ratios (R = F 466 /F 510 ) were calculated. For calibration, the plasma membrane was permeabilized (150 mM b-escin, 4 min), R min and R max were then determined in the absence of b-escin in medium with (R max ) or without (R min ) Ca
2+
. The medium comprised: 140 mM KCl, 10 mM NaCl, 1 mM MgCl 2 , 20 mM HEPES, 3 mM ionomycin, and 3 mM thapsigargin (pH 7.4), and either 0.3 mM EGTA (R min ) or 10 mM CaCl 2 (R max ). [Ca 2+ ] ER was then calculated from the observed fluorescence ratio (R): where n, Hill coefficient (1.37) and K D for Ca 2+ = 558 mM (Suzuki et al., 2014) . A confocal microscope (Zeiss, LSM 710, Axio Observer Z1) with BIG detector was used to capture dual-color images of m-Cherry-er with G-CEPIAer. For comparisons of relative changes in [Ca 2+ ] ER ( Figure 1D) , a cross-sectional view of the intensity values of G-CEPIAer fluorescence over time was generated, and the relative changes in [Ca 2+ ] ER were calculated.
Immunofluorescence and Live-Cell Imaging HLMVECs were fixed with 4% formaldehyde, permeabilized with 0.2% Triton X-100, and immunostained for IP 3 R2 or IP 3 R3 (Supplemental Experimental Procedures). All z stack confocal images (Zeiss LSM 510 META) were acquired with the same settings to allow comparisons of IP 3 R distributions between treatment groups. A projected image was generated by collecting a maximum voxel value through each z stack. The methods used to quantify microtubule dynamics using EB1-GFP, assess the interactions between GFP-IP 3 R3 and EB3-mRFP or mRFP-CLIP-170 using acceptor photobleaching, and to quantify clustering of GFP-IP 3 R3 or immunostained IP 3 R2 and IP 3 R3 are described in Supplemental Experimental Procedures.
Trans-endothelial Electric Resistance Measurements
HPAECs were plated onto gelatin-coated 8W1E gold electrodes (Applied Biophysics), transfected with siRNA, and used after 72 hr (Garcia et al., 2011) . Changes in trans-endothelial electric resistance (TEER) in response to a-thrombin were monitored using an Electric Cell Substrate Impedance Sensing system (Applied Biophysics) and normalized to the basal resistance.
Measurement of Vessel Filtration Coefficient (k fc )
Animal care and handling were performed according to an approved protocol of the University of Illinois at Chicago Animal Care Committee. The transgenic mice are described in Supplemental Experimental Procedures. For measurements of k f,c , isolated lungs were perfused with RPMI medium at constant flow (2 ml/min), temperature (37 C), and venous pressure (4 cm H 2 O) as previously described (Garcia et al., 2011) . The preparation was ventilated at 120 breaths/min with constant peak inspiratory ($10 cm H 2 O) and end expiratory pressures (2 cmH 2 O). Lung weight change was recorded with a forcedisplacement transducer (Model FT03C, Grass Technologies). A 20-min equilibration perfusion established isogravimetric conditions, before measuring the gravimetric filtration coefficient (k f,c ) by comparing the rate of lung weight-gain during a baseline isogravimetric period with the rate after a change in hydrostatic pressure of at least 6 cm H 2 O for 20 min. The filtration rate was determined from the slope of the weight-gain curve between 15 and 20 min after PAR1-AP infusion. k f,c was calculated from:
where W, weight; t, time; P, pulmonary microvascular pressure. Endothelial lysates were collected after each measurement of k f,c via a left atrial cannula perfused with buffer (50 mM Tris-Cl (pH 7.8), 0.2% Triton X-100, and protease and phosphatase inhibitor cocktails; 0.4 ml/min). Fractions were collected at 1-min intervals. Fractions 2 and 3, which were positive for VE-cadherin (endothelial marker) and negative for smooth muscle actin, were used for assessment of EB3 expression by western blot.
Statistical Analyses
Comparisons between groups were made using ANOVA with the Tukey posttest method or Student's t test. Significance values are shown by *p < 0.05, **p < 0.01, and ***p < 0.001. 
SUPPLEMENTAL INFORMATION
